Viking Therapeutics, Inc. ( NASDAQ:VKTX – Get Rating ) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 11,260,000 shares, an increase of 112.1% from the March 15th total of 5,310,000 shares. Based on an average daily volume of 3,860,000 shares, the short-interest ratio is currently 2.9 days. Analysts Set New Price Targets Several research analysts have recently weighed in on the stock. Maxim Group lifted their price target on shares of Viking Therapeutics from $15.

https://www.dailypolitical.com/2023/04/17/short-interest-in-viking-therapeutics-inc-nasdaqvktx-rises-by-112-1.html

#dailypolitical